US Patent Litigations are now available. Check here

PatentPatent Analysis

EP3283058

NOVARTIS
Application Number
EP16718020A
Filing Date
Apr 14, 2016
Status
Granted And Under Opposition
Oct 14, 2022
Grant Date
Nov 16, 2022
External Links
Slate, Register, Google Patents
Similar Patents facing opposition

Biblio Summary

The patent EP3283058B1 was granted on Nov 16, 2022 by Novartis The patent is currently Granted And Under Opposition.

Patent citations in opposition refer to prior patents or publications that may challenge the validity of a contested patent. These references help assess whether the invention is truly novel or overlaps with existing intellectual property.

Citation PhasePatent NumberPatent LinkCited Text
OppositionWO2014097125
N/A
OppositionWO2012064805
N/A
OppositionUS5885617
N/A
OppositionEP2742940
N/A
OppositionWO2016166703
N/A
OppositionWO2022064805
N/A

Dossier Documents of the Patent

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.